Future Market Insights (FMI) presents its new, comprehensive study on the global Light Curable Flowable Composite market spanning from 2017 to 2027. Researches at FMI have no left no stone unturned in bestowing readers a comprehensive view of the market, by studying the drivers, trends, challenges, and restraints. Backed by historical data and projected data, the report …
Category Archives: Healthcare Trends
Radiation-Induced Fibrosis Treatment Market is set to witness a 5.6% growth during the year 2022-2031
According to the latest research by Future Market Insights, Radiation-Induced Fibrosis Treatment market is set to witness a 5.6% growth during the year 2021-2031. The market is expected to witness growth owing to increase in number of patients going through radiotherapy or chemotherapy and the growing utilization of novel drug delivery methods like transdermal patches & combination therapies. …
Radioimmunotherapy Treatment Market Industry Analysis, Opportunities, Technology, Demand, Top Players and Growth Forecast 2027
Cancer is a leading cause of death worldwide and is projected to rise with an estimated 11.5 million deaths in 2030. The most common cancer is lung cancer, accounting about 1.59 million deaths, other types of cancer include liver cancer, breast cancer, stomach cancer, liver cancer, etc. Gain complete access to the report @ https://www.futuremarketinsights.com/reports/radioimmunotherapy-treatment-market …
Retinoids Market is projected to reach US$ 2.5 Bn by the end of 2032 | FMI
[250 Pages Report] The global demand for retinoids is expected to rise at a healthy CAGR of 5.4% per year to US$ 1.5 billion in 2022 Retinoids market is anticipated to grow with a significant growth rate over the forecast period 2018-2028. Retinoids are generally prescribed by dermatologists for mild to moderate acne. Retinoids generally come in three …
Continue reading “Retinoids Market is projected to reach US$ 2.5 Bn by the end of 2032 | FMI”
Saudi Arabia Pharmaceutical Market is predicted to be worth US$ 5,209.5 Mn by the end of 2022, at a CAGR of 9.6% from (2022–2032)
The Saudi Arabia pharmaceutical market is estimated to be valued at US$ 5,209.5 Mn by 2016 end and is expected to expand at a CAGR of 9.0% over the forecast period (2016–2026). The significant rise in lifestyle-related diseases and the developments in healthcare infrastructure are expected to influence the demand for pharmaceuticals in Saudi Arabia. In 2016, …
Self-Ligating Bracket Sales Market Analysis, Recent Trends and Regional Growth Forecast by 2026
The process of correcting the alignment of patient’s teeth with braces can be long, painful and awkward. Just as any other science Orthodontics, has also undergone advances in technology. The aim of these advancements are improving the treatment efficacy with a view to reduce treatment time and providing patients with comfort and achieving the expected …
Self-testing Market is forecast to expand at a significant CAGR of 5.6% to reach US$ 11.55 Billion by 2030 | FMI
[266 Pages Report] As per the latest market study by Future Market Insights (FMI), the global self-testing market is projected to record a CAGR of 5.6% amid the forecast period, 2022-2030. Self-testing Market Size (2022) US$ 7.49 Bn Revenue Forecast (2030) US$ 11.55 Bn Global Market Growth Rate (2022-2030) 5.6% CAGR Dominant Sample Type Urine …
Small Molecule API Market is expected to rise at a yearly growth rate of 5.0% Y-o-Y to US$ 216.97 Billion in 2032
Increasing demand of high potency drugs and increasing cases of chronic diseases are expected to boost small molecule active pharmaceutical ingredient (API) Market. In a study, Future Market Insights (FMI) has forecast the small molecule API market to exhibit 5% CAGR between 2021 and 2031. According to the report, although in-house manufacturing is currently leading the market, …
Oxytocic Pharmaceuticals Market is projected to reach US$ 207.80 Mn by 2031 at a CAGR of 7.74%
Future Market Insights’ published report on the global Oxytocic Pharmaceuticals Market estimates that the market, which is presently valued at US$ 62.2 million, will expand at an impressive 7.74% CAGR to reach US$ 207.80 million value by 2031-end. In the report, titled “Oxytocic Pharmaceuticals Market: Global Industry Analysis & Opportunity Assessment, 2021-2031,” Future Market Insights projects …
PARP Inhibitors Market | TESARO Inc., AbbVie Inc., Pfizer Inc., AstraZeneca | By 2026
The global Poly Adenosine Diphosphate-Ribose Polymerase (PARP) Inhibitors Market is poised for an exponential growth at a CAGR of 11.2% during the forecast period (2022-2026). Strong demand from the flourishing pharmaceutical industries a key contributor for this growth projection. PARP inhibitors have gained noteworthy momentum owing to increased awareness about efficacy in terms of treating different …